Fluorogenic nanocrystals for highly sensitive detection of C-reactive protein

IEE Proceedings: Nanobiotechnology

Volumn 153, Issue 3, 2006, Pages 54-58

  Sin, K K ^a   Chan, C P Y ^b   Leung, W M ^b   Seydack, M ^c   Renneberg, R ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b R and C Biogenius Limited   (Hong Kong)

^c 8sensbiognostic AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE; HYDROLYSIS; MONOCLONAL ANTIBODIES; NANOSTRUCTURED MATERIALS; ORGANIC SOLVENTS; SENSITIVITY ANALYSIS; SODIUM COMPOUNDS;

BLAND-ALTMAN PLOT; C-REACTIVE PROTEIN (CRP); COUPLING BIOMOLECULES; DISTEAROYLGLYCEROPHOSPHOETHANOLAMINE (DSPE); FLUORESCEIN DIACETATE (FDA);

PROTEINS;

3',6' DIACETYLFLUORESCEIN; 3',6'-DIACETYLFLUORESCEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FLUORESCEIN DERIVATIVE; IMMUNOGLOBULIN G; NANOMATERIAL;

AGED; ARTICLE; BLOOD; EVALUATION; FEMALE; FLUOROIMMUNOASSAY; HEART DISEASE; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FLUORESCEINS; FLUOROIMMUNOASSAY; HEART DISEASES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NANOSTRUCTURES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 33745320313     PISSN: 14781581     EISSN: None     Source Type: Journal    
DOI: 10.1049/ip-nbt:20050048     Document Type: Article

References (29)

1. Gabay, C., and Kusher, I.: ' Acute-phase proteins and other systemic responses to inflammation ', The New England Journal of Medicine, 1999, 340, p. 448-454
2. Du Clos, T.W.: ' Function of C-reactive ', Annals of. Medicine, 2000, 32, p. 274-278
3. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P., and Hennekens, C.H.: ' Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men ', The New England Journal of Medicine, 1997, 336, p. 973-979
4. Ridker, P.M., Hennekens, C.H., Buring, J.E., and Rifai, N.: ' C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women ', The New England Journal of Medicine, 2000, 342, (12), p. 836-843
5. Ridker, P.M., Rifai, N., Rose, L., Buring, J.E., and Cook, N.R.: ' Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of the first cardiovascular events ', The New England Journal of Medicine, 2002, 347, p. 1557-1565
6. De Winter, R.J.: ' C-reactive protein and cardiac troponin for early risk stratification in patients with acute coronary syndromes ', Clinica Chimica Acta, 2001, 311, (1), p. 53-56
7. Stampfer, M.J., Ridker, P.M., and Dzau, V.J.: ' Risk factor criteria ', Circulation, 2004, 109, (25 Suppl 1), p. IV3-IV5
8. Ridker, P.M., Brown, N.J., Vaughan, D.E., Harrison, D.G., and Mehta, J.L.: ' Established and emerging plasma biomarkers in the prediction of first atherothrombotic events ', Circulation, 2004, 109, (25 Suppl 1), p. IV6-IV19
9. Nissen, S.E., Tuzcu, E.M., Schoenhagen, P., and Crowe, T.: et al. ' Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease ', The New England Journal of Medicine, 2005, 352, (1), p. 29-38
10. Ridker, P.M., Cannon, C.P., Morrow, D., and Rifai, N.: et al. ' C-reactive protein levels and outcomes after statin therapy ', The New England Journal of Medicine, 2005, 352, (1), p. 20-28
11. Pear, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., and Criqui, M.: ' Marker of inflammation and cardiovascular disease. Application to healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association ', Circulation, 2003, 107, p. 499-511
12. Ridker, P.M.: ' Clinical application of C-reactive protein for cardiovascular disease detection and prevention ', Circulation, 2003, 107, p. 363-369
13. Roberts, W.L., Moulton, L., Law, T.C., Farrow, G., Cooper-Anderson, M., and Savory, J.: ' Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part 2 ', Clinical Chemistry, 2001, 47, p. 418-425
14. Roberts, W.L., Sedrick, R., Moulton, L., Spencer, A., and Rifai, N.: ' Evaluation of four automated high sensitivity C-reactive proteins methods: Implications for clinical and epidemiological applications ', Clinical Chemistry, 2000, 46, p. 461-468
15. Rothkrantz-Kos, S., Schmitz, M.P.J., Bekers, B., Menheere, P.C.A., and Dieijen-Visser, P.V.: ' High-sensitivity C-reactive protein methods examined ', Clinical Chemistry, 2002, 48, p. 359-362
16. Ledue, T.B., and Rifai, N.: ' Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment ', Clinical Chemistry, 2003, 49, (8), p. 1258-1271
17. Ledue, T.B., Weiner, D.L., Sipe, J.D., Poulin, S.E, Collins, M.F., and Rifai, N.: ' Analytical evaluation of particle-enhanced immunonephelometirc assay assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum ', Annals of Clinical Biochemistry, 1998, 35, p. 745-753
18. Rifai, N., Tracy, R.P., and Ridker, P.M.: ' Clinical efficacy of an automated high-sensitivity C-reactive protein assay ', Clinical Chemistry, 1999, 45, p. 2136-2141
19. Peltola, H., Laipio, M.L, and Siimes, M.A.: ' Quantitative C-reactive protein (CRP). Determination by an immunoturbidimetric method in rapid differential diagnosis of acute bacterial and viral disease of children ', Acta Paediatrica Scandinavia, 1984, 73, p. 273-274
20. Keevil, B.G., Nicholls, S.P., and Kilpatrick, E.S.: ' Evaluation of a latex-enhanced immunoturbidimetric assay for measuring low concentrations of C-reactive protein ', Annals of Clinical Biochemistry, 1998, 35, (Pt5), p. 671-673
21. Park, J., Kurosawa, S., Watanabe, J., and Ishihara, K.: ' Evaluation of 2-methacryloyloxyethyl phosphorylcholine polymeric nanoparticle for immunoassay of C-reactive protein detection ', Analytical Chemistry, 2004, 76, (9), p. 2649-2655
22. Deegan, O., Walshe, K., Kavanagh, K., and Doyle, S.: ' Quantitative detection of C-reactive protein using phosphocholine-labelled enzyme or microspheres ', Analytical Biochemistry, 2003, 312, (2), p. 175-181
23. Koskinen, J.O., Vaarno, J., Meltola, N.J., Soini, J.T., Hanninen, P.E., Luotola, J., Waris, M.E., and Soini, A.E.: ' Fluorescent nanoparticles as labels for immunometric assay of C-reactive protein using two-photon excitation assay technology ', Analytical Biochemistry, 2004, 328, (2), p. 210-218
24. Kriz, K., Ibraimi, F., Lu, M., Hansson, L.O., and Kriz, D.: ' Detection of C-reactive protein utilizing magnetic permeability detection based immunoassays ', Analytical Chemistry, 2005, 77, (18), p. 5920-5924
25. Chan, C.P., Bruemmel, Y., Seydack, M., Sin, K.K., Wong, L.W., Merisko-Liversidge, E., Trau, D., and Renneberg, R.: ' Nanocrystal biolabels with releasable fluorophores for immunoassays ', Analytical Chemistry, 2004, 76, (13), p. 3638-3645
26. Trau, D., Yang, W., Seydack, M., Caruso, F., Yu, N.T., and Renneberg, R.: ' Nanoencapsulated microcrystalline particles for superamplified biochemical assays ', Analytical Chemistry, 2002, 74, (21), p. 5480-5486
27. Hermanson, G.T.: ' Bioconjugate techniques ', (Academic Press, NewYork 1996)
28. Zalipsky, S., Qazen, M., Walker, J.A., Mullah, N., Quinn, Y.P., and Huang, S.K.: ' New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine ', Bioconjugate Chemistry, 1999, 10, p. 703-707
29. Sin, K.K., Chan, C.P., Pang, T.T., Seydack, M., and Renneberg, R.: ' A highly sensitive fluorescent immunoassay based on avidn labeled nanocrystals ', Analytical and Bioanalytical Chemistry;, 2006, 384, (3), p. 638-644.